** Telehealth firm Teladoc Health's TDOC.N shares rise 3.5% to $9.35 premarket
** Teladoc Health and LifeMD LFMD.O say they have tied up with Gifthealth, the pharmacy partner of Eli Lilly's LLY.N direct-to-consumer website LillyDirect, to offer patients the weight-loss drug Zepbound
** Tie-up allows eligible members to gain access to single-use vials that can be delivered directly to their home
** Last week, Lilly began selling higher doses of Zepbound in vials in the U.S. at a $150 discount to the cost of the injector pen versions
** TDOC has fallen 37.5% in the past 12 months
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。